Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maridose is a specialized biotechnology company that holds a rare DEA Bulk Manufacturer license for the cultivation and production of cannabis for research purposes. Based in Maine, the company provides pharmaceutical-grade cannabis and cannabis-derived products to researchers, universities, and pharmaceutical companies conducting clinical trials. Their mission is to provide standardized, high-quality materials that meet the rigorous requirements of the FDA and DEA, facilitating the development of new cannabinoid-based medicines. By offering a variety of strains and delivery formats, Maridose supports the scientific community in exploring treatments for conditions such as chronic pain, PTSD, and epilepsy. The company's operations represent a significant shift in the U.S. cannabis research landscape, providing an alternative to the previously limited federal supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maridose.